1. Home
  2. SABS vs RAY Comparison

SABS vs RAY Comparison

Compare SABS & RAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SABS
    SELLHOLDBUYas of 4 hours ago
  • RAY
    SELLHOLDBUYas of 2024 years ago
  • Stock Information
  • Founded
  • SABS 2014
  • RAY 1993
  • Country
  • SABS United States
  • RAY Hong Kong
  • Employees
  • SABS N/A
  • RAY N/A
  • Industry
  • SABS Biotechnology: Pharmaceutical Preparations
  • RAY Consumer Electronics/Appliances
  • Sector
  • SABS Health Care
  • RAY Consumer Discretionary
  • Exchange
  • SABS Nasdaq
  • RAY Nasdaq
  • Market Cap
  • SABS 19.0M
  • RAY 21.7M
  • IPO Year
  • SABS N/A
  • RAY 2024
  • Fundamental
  • Price
  • SABS $1.10
  • RAY $1.83
  • Analyst Decision
  • SABS Strong Buy
  • RAY
  • Analyst Count
  • SABS 5
  • RAY 0
  • Target Price
  • SABS $11.40
  • RAY N/A
  • AVG Volume (30 Days)
  • SABS 39.3K
  • RAY 7.1M
  • Earning Date
  • SABS 05-19-2025
  • RAY 02-20-2025
  • Dividend Yield
  • SABS N/A
  • RAY N/A
  • EPS Growth
  • SABS N/A
  • RAY N/A
  • EPS
  • SABS N/A
  • RAY 0.06
  • Revenue
  • SABS $1,322,410.00
  • RAY $9,936,869.00
  • Revenue This Year
  • SABS N/A
  • RAY N/A
  • Revenue Next Year
  • SABS $25.00
  • RAY N/A
  • P/E Ratio
  • SABS N/A
  • RAY $29.66
  • Revenue Growth
  • SABS N/A
  • RAY 28.52
  • 52 Week Low
  • SABS $1.11
  • RAY $0.86
  • 52 Week High
  • SABS $5.01
  • RAY $6.04
  • Technical
  • Relative Strength Index (RSI)
  • SABS 28.53
  • RAY N/A
  • Support Level
  • SABS $1.11
  • RAY N/A
  • Resistance Level
  • SABS $1.80
  • RAY N/A
  • Average True Range (ATR)
  • SABS 0.14
  • RAY 0.00
  • MACD
  • SABS -0.02
  • RAY 0.00
  • Stochastic Oscillator
  • SABS 6.70
  • RAY 0.00

Stock Price Comparison Chart: SABS vs RAY

SABS
RAY
JulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025April0102030405060708090100110120SABS VS RAY

About SABS SAB Biotherapeutics Inc.

SAB Biotherapeutics Inc is a clinical stage biopharmaceutical company focused on the development and commercialization of a portfolio of products from its proprietary immunotherapy platform to produce fully targeted human polyclonal antibodies, without using human plasma or serum. The company's novel DiversitAb platform enables the rapid production of large amounts of targeted human polyclonal antibodies, leveraging transchromosomic cattle (Tc Bovine) that have been genetically designed to produce human antibodies (immunoglobulin G) rather than bovine in response to an antigen. Animal antibodies have been made in rabbits, sheep and horses.

About RAY Raytech Holding Limited Ordinary Shares

Raytech Holding Ltd is principally engaged in product designing and manufacturing of various product ranges such as Hair Care, Men's Care and Women's Care products. It has sourced and wholesaled a wide range of personal care electrical appliances, which can be broadly classified into seven categories: hair styling series, including hair dryer, hair straightener and curling iron; trimmer series, including facial shaver, nose trimmer and eyebrow trimmer; eyelash curler; neck care series; nail care series; tooling and other personal care appliances such as body and facial brush, reset brush, callus remover, sonic peeling, handy fan and others. Raytech manufactures products under OEM and ODM.

Share on Social Networks:

0

By browsing this website, you accept our Privacy Policy & Terms of Use